As part of an ongoing Senate investigation into pharma companies’ tax rates, Sen. Ron Wyden (D … The Democratic senator contends that the … As part of …
Full story here.
Published by www.biospace.com
Visited 1 times, 1 visit(s) today
May 22, 2024• byQuorum Call
As part of an ongoing Senate investigation into pharma companies’ tax rates, Sen. Ron Wyden (D … The Democratic senator contends that the … As part of …